Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT02221752 |
Date of registration:
|
18/08/2014 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Impact of Iron/Folic Acid vs Folic Acid Supplements During Pregnancy on Maternal and Child Health
|
Scientific title:
|
Impact of Iron/Folic Acid Versus Folic Acid Supplements During Pregnancy on Maternal and Children's Health: A Randomized Controlled Trial in China |
Date of first enrolment:
|
June 2009 |
Target sample size:
|
2367 |
Recruitment status: |
Completed |
URL:
|
http://clinicaltrials.gov/show/NCT02221752 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention
|
Phase:
|
N/A
|
|
Countries of recruitment
|
China
| | | | | | | |
Contacts
|
Name:
|
Zhao Gengli, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Peking University First Hospital |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- uncomplicated singleton pregnancy, first enrollment visit = 20 weeks gestation -
Exclusion Criteria:
- < 18 years of age
- did not live in the county
- did not anticipate delivery at participating hospital
- were not mentally competent
- had a chronic health problem or hemoglobin < 100 g/L at the initial visit
- were taking iron at the time.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Female
|
Health Condition(s) or Problem(s) studied
|
Iron Deficiency
|
Iron Deficiency Anemia
|
Intervention(s)
|
Dietary Supplement: Ferrous Sulfate + folic acid
|
Dietary Supplement: Folic acid
|
Primary Outcome(s)
|
Maternal iron status at follow-up prenatal visit
[Time Frame: 36-40 weeks]
|
Maternal iron status at follow-up prenatal visit
[Time Frame: 26-30 weeks]
|
Secondary Outcome(s)
|
Infant birth weight
[Time Frame: delivery]
|
Infant gestational age
[Time Frame: delivery]
|
Cord-blood iron status
[Time Frame: delivery]
|
Secondary ID(s)
|
Vifor/PFH supplement trial
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|